Compare KB & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KB | MDLN |
|---|---|---|
| Founded | 2008 | 1966 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.2B | 37.4B |
| IPO Year | 2008 | 2025 |
| Metric | KB | MDLN |
|---|---|---|
| Price | $118.72 | $34.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 23 |
| Target Price | N/A | ★ $50.48 |
| AVG Volume (30 Days) | 192.1K | ★ 7.0M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $28,432,000,000.00 |
| Revenue This Year | $18.22 | $10.88 |
| Revenue Next Year | $3.21 | $7.69 |
| P/E Ratio | ★ $9.90 | $148.96 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $76.31 | $32.49 |
| 52 Week High | $125.66 | $50.88 |
| Indicator | KB | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.44 | 43.08 |
| Support Level | $114.71 | $33.52 |
| Resistance Level | $119.71 | $43.31 |
| Average True Range (ATR) | 2.00 | 1.60 |
| MACD | -0.64 | -0.17 |
| Stochastic Oscillator | 42.79 | 39.22 |
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.